VSA012
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for VSA012, covering 2025-01-09 to 2025-02-27. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of of VSA012 in Subjects with Paroxysmal Nocturnal Hemoglobinuria(PNH)